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 In-Press Preview 
Nemaline myopathy is a congenital neuromuscular disorder characterized by muscle
weakness, fiber atrophy and presence of nemaline bodies within myofibers. However, the
understanding of underlying pathomechanisms is lacking. Recently, mutations in
KBTBD13, KLHL40 and KLHL41, three substrate adaptors for the E3-ubiquitin ligase
Cullin-3, have been associated with early-onset nemaline myopathies. We hypothesized
that deregulation of Cullin-3 and its muscle protein substrates may be responsible for the
disease development. Using Cullin-3 knockout mice, we identified accumulation of non-
muscle alpha-Actinins (ACTN1 and ACTN4) in muscles of these mice, which we also
observed in KBTBD13 patients. Our data reveal that proper regulation of Cullin-3 activity
and ACTN1 levels is essential for normal muscle and neuromuscular junction development.
While ACTN1 is naturally downregulated during myogenesis, its overexpression in C2C12
myoblasts triggered defects in fusion, myogenesis and acetylcholine receptor clustering;
features that we characterized in Cullin-3 deficient mice. Taken together, our data highlight
the importance for Cullin-3 mediated degradation of ACTN1 for muscle development, and
indicate a new pathomechanism for the etiology of myopathies seen in Cullin-3 knockout
mice and nemaline myopathy patients.
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Nemaline	 myopathy	 is	 a	 congenital	 neuromuscular	 disorder	 characterized	 by	 muscle	
weakness,	 fiber	atrophy	and	presence	of	nemaline	bodies	within	myofibers.	However,	
the	 understanding	 of	 underlying	 pathomechanisms	 is	 lacking.	 Recently,	 mutations	 in	
KBTBD13,	 KLHL40	 and	 KLHL41,	 three	 substrate	 adaptors	 for	 the	 E3-ubiquitin	 ligase	
Cullin-3,	have	been	associated	with	early-onset	nemaline	myopathies.	We	hypothesized	
that	deregulation	of	Cullin-3	and	 its	muscle	protein	 substrates	may	be	 responsible	 for	
the	disease	development.			
Using	Cullin-3	knockout	mice,	we	identified	accumulation	of	non-muscle	alpha-Actinins	
(ACTN1	 and	 ACTN4)	 in	 muscles	 of	 these	 mice,	 which	 we	 also	 observed	 in	 KBTBD13	
patients.	Our	data	reveal	that	proper	regulation	of	Cullin-3	activity	and	ACTN1	levels	is	
essential	for	normal	muscle	and	neuromuscular	junction	development.	While	ACTN1	is	
naturally	 downregulated	 during	 myogenesis,	 its	 overexpression	 in	 C2C12	 myoblasts	








muscle	 atrophy,	 reflecting	 the	 balance	 between	 protein	 synthesis	 and	 degradation	 at	
the	cellular	level.	This	balance	is	affected	in	pathologies	such	as	cancer,	HIV	or	diabetes	
leading	 to	 muscle	 atrophy	 and	 reduced	 lifespan	 (1).	 Accumulation	 of	 undegraded	
proteins	 in	 aggrosomes	 or	 inclusion	 bodies	 is	 often	 associated	 with	 development	 of	
skeletal	muscle	myopathies,	like	nemaline	or	reducing-body	myopathy	(2).	Indeed,	there	
is	 mounting	 evidence	 that	 the	 deregulation	 of	 protein	 turnover	 is	 the	 primary	
pathogenic	 mechanism	 for	 some	 forms	 of	 skeletal	 myopathies.	 Hence,	 a	 deeper	
understanding	 of	 the	 mechanisms	 that	 govern	 muscle	 protein	 degradation	 may	
contribute	to	the	development	of	treatments	and	prevention	of	these	pathologies.		
Muscle	 cells	 contain	 two	 major	 systems	 for	 protein	 degradation:	 the	 autophagy-
lysosome,	and	the	ubiquitin-proteasome	systems	(UPS).	The	latter	is	responsible	for	the	
degradation	of	80%	of	muscle	proteins.	The	UPS	requires	 the	 tagging	of	 substrates	by	
poly-ubiquitin	 chains	 via	 an	 enzymatic	 cascade	 (3).	 First,	 the	 E1-activating	 enzyme	
covalently	attaches	to	ubiquitin	through	an	ATP-driven	step.	Once	activated,	ubiquitin	is	
transferred	 to	E2-conjugating	enzymes.	 The	 last	 step	 requires	 the	 concerted	action	of	
E2-enzymes	 and	 E3-ligases,	 which	 transfer	 ubiquitin	 from	 the	 E2-enzyme	 onto	 the	
substrate	 (3).	Once	poly-ubiquitylated,	 the	 substrate	 is	 recognized	by	 the	proteasome	
for	degradation.	
Cullin-RING	ligases	(CRL)	represent	the	largest	E3-ubiquitin	ligase	family	in	mammals	(4,	
5).	 Cullin	 (1-3,	 4a,	 4b,	 5,	 7,	 9)	 proteins	 are	 nearly	 ubiquitously	 expressed	 (6)	 and	
constitute	the	backbone	of	this	complex.	In	order	to	form	the	functioning	CRL	complex,	
each	 Cullin	 binds	 to	 one	 of	 two	 RING	 (Really	 Interesting	New	Gene)	 domain	 proteins	
(Rbx1	or	Rbx2)	that	associates	with	E2	conjugating	enzymes.	In	addition,	Cullins	interact	
with	specific	substrate	adaptor	protein	families,	thereby	achieving	specificity	for	a	range	
of	 cellular	 substrates	 (7).	 The	 activity	 of	 CRLs	 is	 regulated	 through	 posttranslational	
modification	 of	 the	 Cullin	 backbone	 by	 the	 small	 ubiquitin-like	 modifier	 Nedd8,	 also	
called	neddylation	(7).	Cullin	neddylation	is	removed	by	the	COP9	signalosome	complex,	
leading	to	the	inactivation	of	the	CRL	(8).	
For	 the	 last	 decades,	 Cullin	 proteins	 were	 mainly	 studied	 in	 the	 context	 of	 cancer	




were	 found	 to	 exhibit	 key	 roles	 during	muscle	 atrophy	 (10).	We	have	 recently	 shown	
that	 neddylation	 and	 CRL	 activity	 is	 necessary	 for	 normal	 myoblast	 differentiation,	
fusion	and	maturation	in	vitro	(11).	
Cullin-3	is	highly	enriched	in	muscle	tissues	(6),	localizes	to	myofilaments	and	is	involved	
in	muscle	protein	breakdown	 in	adult	animals	 (12).	Cullin-3	utilizes	 the	 large	 family	of	
BTB-domain-containing	proteins	as	substrate	adaptors.	A	prominent	subset	of	the	BTB-
protein	 family	 with	 roles	 in	 skeletal	muscles	 is	 the	 BTB/Kelch-adaptor	 protein	 family,	
characterized	by	their	combination	of	BTB-	and	Kelch-repeat	domains	(13).	Proteins	of	
this	family	are	involved	in	a	plethora	of	molecular	and	cellular	mechanisms	such	as	cell	
migration,	morphology	or	 protein	 expression	 (13).	 Very	 recently,	mutations	 in	 several	
BTB/Kelch	 genes	 (i.e.	KLHL9,	KLHL40,	KLHL41	 and	KBTBD13)	were	 associated	with	 the	
development	of	distal	and	nemaline	myopathies	in	patients	(13-17).	The	early	onset	of	
these	 myopathies	 suggests	 important	 roles	 for	 Cullin-3	 and	 its	 associated	 protein	
turnover	for	skeletal	muscle	development.	
While	 many	 BTB/Kelch-domain	 proteins	 may	 be	 Cullin-3	 substrate	 adaptors,	 their	
substrates	 in	skeletal	muscles	remain	 largely	unknown.	However,	KLHL40	was	recently	
shown	 to	 be	 necessary	 for	 postnatal	 muscle	 growth	 through	 the	 degradation	 of	
dimerization	 partner	 1	 (DP1)	 and	 the	 subsequent	 repression	 of	 E2F1-DP1	 complex	
activity	(18).	Unexpectedly,	KLHL40	also	acts	as	a	stabilizer	of	the	thin	filament	proteins	
Leiomodin-3	and	Nebulin	 (19).	This	 last	discovery	suggests	non-canonical	 functions	 for	
the	Cullin-3	E3-ligase	complex	that	could	also	be	important	for	the	stabilization	of	some	
substrate	proteins	 rather	 than	 their	 degradation.	 These	 findings	 add	 a	 new	degree	of	
complexity	 to	 the	 protein	 turnover	 mechanism	 related	 to	 Cullin-3.	 Therefore,	 the	
discovery	 of	 new	 substrates	 for	 Cullin-3	 during	 muscle	 development	 will	 be	 of	 great	
interest	 for	 a	 better	 understanding	 of	 myogenesis	 and	 pathogenesis	 of	 associated	
myopathies.	While	their	functions	are	mainly	unknown	in	muscles,	expression	patterns	
of	 other	 BTB/Kelch-domain	 proteins	 suggest	 important	 roles	 during	 muscle	
development	 (13).	 These	 findings	 represent	 an	 emerging	 role	 for	 Cullin-3	 in	 muscle	
homeostasis.	 Indeed,	 characterizing	 the	 specific	 function(s)	 of	 Cullin-3	 and	 its	 related	
protein	 turnover	 during	 muscle	 development	 would	 increase	 our	 understanding	 of	
muscle	biology	as	well	as	pathological	mechanisms	for	the	etiology	of	muscle	diseases,	
like	nemaline	myopathy.		
While	 writing	 this	 manuscript,	 an	 article	 investigating	 the	 role	 of	 Cullin-3	 in	 striated	
muscles	was	published	 (20).	 The	 authors	demonstrated	 that	Cullin-3	was	 required	 for	
striated	 muscle	 development,	 a	 finding	 that	 our	 studies	 fully	 support.	 However,	 no	
molecular	mechanism	that	explained	some	of	the	observed	muscle	defects	were	given.		
We	 performed	 in-depth	 characterization	 of	 mice	 lacking	 Cullin-3	 in	 skeletal	 muscles.	
Specifically,	we	focused	on	the	role	of	Cullin-3	for	the	diaphragm,	a	hot-spot	for	Cullin-3	
substrate	 adaptor	 function.	 Our	 data	 show	 the	 importance	 of	 Cullin-3	 for	 myoblast	
fusion,	 differentiation	 and	 neuromuscular	 junction	 (NMJ)	 establishment	 through	 the	
modulation	of	actin	dynamics	and	the	regulation	of	protein	levels	for	non-muscle	alpha-
actinin	 isoforms	 ACTN1	 and	 ACTN4.	 Finally,	 we	 also	 found	 specific	 accumulation	 of	
ACTN1	 and	 ACTN4	 only	 in	 the	 muscles	 of	 patients	 suffering	 from	 Cullin-3	 related	
nemaline	 myopathy,	 characterized	 by	 mutations	 in	 KBTBD13.	 In	 addition,	 our	 study	





with	 transgenic	 animals	 that	 express	 cre-recombinase	 under	 the	 control	 of	 the	
myogenin	promoter	and	the	MEF2C	enhancer	(22)	(Supplementary	Figures	S1A-B).	The	
transcript	 and	 protein	 levels	 of	 Cullin-3	were	 subsequently	monitored	 by	 RT-PCR	 and	
immunoblot	analyses.	Efficient	recombination	of	the	Cullin-3	gene	was	observed	only	in	
skeletal	muscles	of	Cul3flox/flox;cre+	embryos,	thereafter	designated	as	skm-KO	(Figure	1A	
and	 Supplementary	 Figure	 S1C).	 In	 diaphragms,	 protein	 levels	 of	 Cullin-3	 were	
diminished	by	70%	compared	 to	 controls	 (Figure	1A-B).	 	Remaining	Cullin-3	was	 likely	
due	to	its	expression	in	other	cell-types	that	are	present	in	skeletal	muscles	(e.g.,	blood	
vessels,	neural	tissues	or	fibroblasts).	Analysis	of	Cullin-3	protein	levels	in	other	tissues	
did	 not	 reveal	 significant	 changes	 (Figure	 1A).	We	 did	 not	 identify	 changes	 in	 mRNA	
levels	of	other	Cullin	family	members	(Supplementary	Figure	S1D).	
Changes	 to	 global	 protein	 neddylation	 was	 assessed	 by	 immunoblot	 analysis,	 and	
revealed	a	45%	decrease	in	the	80kDa	band,	consistent	with	the	predicted	sizes	of	most	
Nedd8-modified	Cullin	proteins	(23,	24)	(Figure	1C-D).	This	substantial	change	suggests	
that	 Cullin-3	 represents	 a	 major	 constituent	 of	 all	 active	 Cullins	 detected	 in	 the	
developing	skeletal	muscles.	Analysis	of	K48-linked	poly-ubiquitylated	substrates,	which	
are	 normally	 targeted	 to	 the	 proteasome	 for	 degradation	 revealed	 a	 decrease	 of	 low	
molecular	weight	bands	(Figure	1E).	Because	the	UPS	and	autophagy-lysosome	system	
are	 interconnected,	we	 assessed	 p62	 protein	 levels	 as	marker	 for	 changes	 to	 cellular	
autophagy.	Levels	of	p62	in	skm-KO	were	unchanged	compared	to	controls	(Figure	1E),	
excluding	 compensatory	 mechanisms	 played	 by	 the	 autophagy-lysosome	 system	 to	
overcome	deficiency	of	 the	ubiquitin-proteasome	pathway.	 	Summarized,	depletion	of	














weakness.	To	evaluate	 if	 skm-KO	 embryos	were	able	 to	breathe,	 lungs	were	collected	
and	placed	immediately	on	the	surface	of	water.	In	contrast	to	controls,	lungs	of	skm-KO	
embryos	 sank,	 indicating	 that	 they	 had	 never	 been	 inflated	 (Figure	 2C).	 Histological	
analyses	showed	that	 lung	alveoli	of	skm-KO	embryos	were	not	expanded	(Figure	2D),	
again	 indicating	 that	 skm-KO	 embryos	 were	 unable	 to	 breathe.	 Our	 data	 confirm	






Focusing	on	E18.5	 skm-KO	embryos,	we	 found	a	22.3%	decrease	 in	 their	body	weight	
compared	 to	 controls	 (ctl=1.35±0.02g,	 skm-KO=1.05±0.02g;	 p>0.0001;	 Figure	 3A).	
However,	 tibia	 lengths	 were	 not	 significantly	 changed	 (ctl=1.8±0.2cm,	 skm-
KO=1.7±0.2cm;	n=5	for	each	genotype).	These	data	 indicate	that	the	decrease	 in	body	
weight	is	not	due	to	global	prenatal	growth	retardation	but	may	be	more	attributed	to	a	
65%	decrease	 in	 skeletal	muscle	mass	 (Figure	 3B,	 Supplementary	 Figure	 S3A).	 Loss	 of	
skeletal	muscles	was	also	observable	in	diaphragm	and	hindlimb	cross-sections	stained	
with	 Hematoxylin-Eosin	 (Figure	 3C	 and	 Supplementary	 Figures	 S3B-C).	 Masson’s	
trichrome	 did	 not	 reveal	 abnormal	 fibrosis	 (not	 shown).	 However,	 Gomori’s	modified	
trichrome	 staining	 showed	 presence	 of	 aggregates	 (Supplementary	 Figure	 S3D).	 This	
phenotype	was	 reminiscent	 of	 observations	made	 in	 nemaline	myopathies	 associated	
with	mutations	in	genes	encoding	for	substrate	adaptors	of	Cullin-3	(13).	
Because	 mutations	 in	 genes	 encoding	 for	 Cullin-3	 substrate	 adaptors	 are	 mainly	
associated	with	early	onset	myopathies	 (13),	we	hypothesized	that	muscle	maturation	
in	 absence	 of	 Cullin-3	 may	 be	 affected.	 We	 assessed	 several	 sarcomeric	 proteins,	
markers	 of	 mature	 muscles,	 and	 found	 a	 severe	 decrease	 in	 the	 expression	 of	
sarcomeric	 Myosin	 Heavy	 Chain,	 Desmin	 and	 Filamin-C	 (Figure	 3D,	 Supplementary	
Figures	 S4A-C).	 We	 also	 noticed	 trends	 towards	 decreased	 expression	 of	 sarcomeric	
alpha-actinin	2	(ACTN2)	and	increased	expression	of	ACTN3	(Figure	3D,	Supplementary	
Figure	 S4D-E)	 in	 skm-KO	 diaphragms.	 However,	 none	 of	 these	 changes	 reached	
significance.	 During	 development,	myonuclei	 first	 locate	 to	 the	 center	 of	 fibers,	 then	
migrate	 to	 the	 periphery	 in	 more	 mature	 muscles	 (25).	 In	 skm-KO,	 we	 observed	 a	
widespread	 presence	 of	 centralized	 nuclei	 while	 they	 were	 mainly	 found	 at	 the	
periphery	in	controls	(Figure	3E	and	Figure	4A).	Altogether	these	data	are	suggestive	of	
a	muscle	maturation	defect.		
In	order	 to	 investigate	 the	pathogenic	mechanism,	we	assessed	 if	 the	 reduced	muscle	
mass	 relied	 on	 hypotrophy	 (a	 decrease	 in	 the	 size	 of	 the	 fibers)	 or	 hypoplasia	 (a	
decrease	 in	 the	 number	 of	 fibers).	 We	 stained	 diaphragms	 of	 control	 and	 skm-KO	
embryos	with	Wheat	Germ	Agglutinin	(WGA)	in	order	to	delineate	individual	myofibers	
and	 analyze	 their	 sizes	 and	 numbers.	 The	 mean	 fiber	 cross-sectional	 area	 (CSA)	 was	
reduced	 by	 62%	 (ctl=95±5.06µm2,	 skm-KO	 =32±1.51µm2;	 p<0.0001,	 Figure	 4A	 and	
Supplementary	 Figure	 S4F)	 and	 the	 distribution	 of	 fiber	 CSAs	 was	 shifted	 towards	
smaller	 diameters	 in	 comparison	 with	 controls	 (Figure	 4B).	 However,	 the	 number	 of	
fibers	 constituting	 the	 diaphragm	 was	 unchanged	 (ctl=3076±230,	 skm-KO=2654±470;	
Supplementary	Figure	S4G),	 suggesting	 that	 fiber	hypotrophy	was	accountable	 for	 the	
reduced	muscle	mass.			
It	 is	 established	 that	 during	 early	 steps	 of	 muscle	 development,	 myoblast	 fusion	
represents	a	limiting	step	for	optimal	myofiber	size	and	muscle	mass	(26-33).	We	tested	
if	 a	 defect	 in	 myoblast	 fusion	 could	 be	 responsible	 for	 the	 muscle	 fiber	 hypotrophy	
observed	in	embryonic	skm-KO	diaphragms.	We	isolated	myoblasts	from	E18.5	control	
and	 skm-KO	muscles	 and	 validated	 that	 skm-KO	myoblasts	 undergo	 recombination	 of	
the	Cullin-3	locus	upon	expression	of	myogenin	during	differentiation	(Figure	4C).			
We	then	assessed	myoblast	fusion	after	3	days	of	differentiation	and	observed	a	defect	
in	 skm-KO	 myotube	 formation	 (Figure	 4D).	 skm-KO	 myoblasts	 expressed	 myogenic	
factors	such	as	MyHC	but	did	not	form	long	myotubes	(Figure	4D)	as	confirmed	by	the	
decrease	 in	 their	 fusion	 index	 defined	 as	 the	 number	 of	 nuclei	 per	 myotube	
(Supplementary	Figure	S4H),	pointing	out	a	fusion	defect.		
To	 confirm	 these	 results,	 we	 transfected	 C2C12	 cells	 with	 siRNA	 against	 Cullin-3	 and	
monitored	 their	differentiation.	We	 found	a	72%	decrease	 in	Cullin-3	protein	 levels	 in	
cells	expressing	the	siRNA	compared	to	cells	expressing	scrambled	siRNA	(Figure	4E	and	
Supplementary	 Figure	 S4I).	 	 We	 then	 assessed	 myoblast	 fusion	 5	 days	 after	




Summarized,	 our	 data	 indicate	 that	 lack	 of	 Cullin-3	 impedes	 a	 step	 required	 for	 the	
fusion	of	myoblasts	and	maturation	of	muscle	fibers.	
		
Absence	 of	 Cullin-3	 affects	 proteins	 involved	 in	 degradation,	 calcium	 signaling,	
metabolism,	muscle	contraction	and	actin	modulation.		
Next,	 we	 aimed	 at	 identifying	 molecular	 mechanisms	 underlying	 the	 muscle	 defects	
observed	 in	 skm-KO	 embryos	 in	 order	 to	 better	 characterize	 Cullin-3	 functions	 during	
skeletal	muscle	development.	While	Cullin	proteins,	such	as	Cullin-1	and	Cullin-3,	were	
broadly	expressed	in	various	adult	skeletal	muscles,	diaphragm	was	a	hot	spot	for	BTB-
domain	 proteins	 (Cullin-3	 substrate	 adaptors)	 including	 KBTBD5,	 KBTBD13,	 KLHL9,	
KCTD6	and	PLZF,	with	the	exception	of	KCTD9	(Figure	5A).	To	maximize	the	chances	for	
identifying	 substrates	of	Cullin-3	and	 changes	 to	proteins	 that	may	be	 responsible	 for	
the	 observed	 phenotype,	 we	 performed	 an	 unbiased	 large-scale	 proteome	 analysis	
using	 E18.5	 diaphragms.	 Our	 analysis	 revealed	 that	 6%	 of	 detected	 proteins	 were	
significantly	altered	in	absence	of	Cullin-3	(Supplementary	Figure	S5A).	Among	those,	26	
proteins	 were	 significantly	 accumulated	 in	 skm-KO	 diaphragms,	 while	 100	 were	
significantly	down	regulated	(Figure	5B).	
Functional	 analyses	 aided	 by	 DAVID	 (https://david.ncifcrf.gov)	 and	 Metascape	
(http://metascape.org/)	revealed	that	deregulated	proteins	might	be	grouped	into	five	
categories:	 heat	 shock	 proteins	 and	 degradation	 pathways,	 muscle	 and	 calcium	
associated	 proteins,	 proteins	 associated	 with	 metabolism	 and	 mitochondria,	
ribonucleoproteins	 and	 DNA-associated	 proteins,	 and	 proteins	 involved	 in	 actin	
modulation	(Figure	5B,	Supplementary	Figures	S5B-D).	Of	note,	KLHL41	and	KLHL31,	two	
substrate	adaptors	involved	in	muscle	physiology	(15,	34,	35)	were	strongly	decreased	in	
skm-KO	 muscles	 (Supplementary	 Figure	 S5D),	 suggesting	 a	 destabilization	 of	 these	
proteins	 in	 absence	 of	 Cullin-3.	 Altered	 proteins	 involved	 in	 muscle	 and	 calcium	
physiology,	metabolism	and	mitochondria,	HSP	and	degradation	pathways	were	mainly	
down-regulated,	 whilst	 ribonucleoproteins	 and	 DNA-associated	 proteins	 were	
accumulated.	 To	 validate	 our	 proteome	 analysis,	 we	 studied	 the	 expression	 of	










Among	 them,	 non-muscle	 ACTN1	 and	 ACTN4	 isoforms	 were	 the	 most	 significantly	
accumulated.	 ACTN4s	 role	 in	 skeletal	 muscles	 has	 been	 investigated.	 Surprisingly,	
ACTN4	 overexpression	 seemed	 to	 enhance	 myoblast	 differentiation	 (38).	 Hence,	 we	
focused	on	the	role	that	ACTN1	may	play	in	our	phenotype.		
We	first	confirmed	the	accumulation	of	ACTN1	in	knockout	muscles	(Figures	6A-B)	using	
an	 antibody	 that	 has	 been	 validated	 on	 muscle	 cells	 transfected	 with	 siRNA	 against	
ACTN1	 (Supplementary	 Figure	 S6A).	 In	 skm-KO	 myoblasts,	 we	 also	 observed	
accumulation	 of	 ACTN1	 during	 differentiation	 (Figure	 6C-D),	 suggesting	 that	














during	muscle	 cell	 differentiation.	 In	 proliferative	 C2C12	 cells,	 ACTN1	 localized	 at	 the	
edge	of	the	cells	and	along	the	actin	stress	fibers	and	focal	contacts,	confirming	previous	
data	 in	 other	 cell	 types	 ((39)	 and	 Supplementary	 Figure	 S6E).	 Three	 days	 after	
differentiation,	when	myoblast	fusion	occurs,	ACTN1	staining	became	more	fragmented	
in	a	subset	of	cells.	In	other	cells,	it	retained	its	localization	along	actin	stress	fibers	and	
focal	 adhesion	 contacts	 (Supplementary	 Figure	 S6E).	 Finally,	 five	 days	 after	
differentiation,	while	ACTN1	still	localized	at	the	edge	of	mono-nucleated	and	non-fused	
cells,	 it	 was	 weakly	 expressed	 and	 diffusely	 localized	 in	 the	 cytoplasm	 of	 myotubes.	








Figure	 S7A)	 and	 monitored	 their	 differentiation.	 Five	 days	 after	 differentiation,	 HA-
ACTN1	 overexpressing	 cells	 displayed	 a	 reduction	 in	 the	 ability	 to	 form	 myotubes,	
compared	to	control	cells	(Figure	7B),	accompanied	by	a	slight	but	consistent	decrease	
of	MyHC	expression	(Figure	7A	and	Supplementary	Figure	S7B).	Our	analyses	indicated	a	
44%	decrease	 in	 the	 fusion	 index	of	HA-ACTN1	cells	 compared	 to	 controls	 (Figure	7C)	
due	to	an	over-representation	of	small	myotubes	(2-4	nuclei),	and	an	almost	complete	
loss	of	myotubes	containing	larger	amounts	of	nuclei	(≥54	nuclei)	(Figure	7D).		
Altogether	 our	 data	 suggest	 that	 accumulation	 of	 ACTN1	 impaired	 the	 fusion	 of	








Impairment	 of	 NMJ	 development	 often	 results	 in	 respiratory	 defects	 due	 to	 the	
dysfunction	 of	 the	 diaphragm	 and	 intercostal	 muscles	 (40).	 Importantly,	 a	 striking	
sustained	 and	 beneficial	 effect	 of	 acetylcholine-esterase	 inhibitor	 treatment	 has	 been	
observed	 in	 a	 patient	 affected	 by	 KLHL40-related	 nemaline	 myopathy,	 another	
confirmed	substrate	adaptor	 for	Cullin-3	 (41).	 In	addition,	sarcomeric	ACTN2	has	been	
shown	 to	 interact	 with	 rapsyn	 (42),	 and	 active	 actin	 cytoskeleton	 remodeling	 is	
absolutely	 required	 for	 proper	 Acetylcholine	 receptor	 (AchR)	 clustering	 and	 NMJ	
development	(43).		
Cullin	E3-ligase	activity	is	required	for	normal	AchR	clustering	in	vitro	(11,	44).		
We	 first	monitored	 Cullin-3	 expression	 following	 stimulation	 of	 C2C12	myotubes	with	
neural	agrin.	We	observed	that	Cullin-3	was	significantly	increased	upon	AchR	clustering	
(Figure	8A	and	Supplementary	Figure	S8A),	suggesting	a	role	during	NMJ	development.	
We	 then	 looked	 at	 the	 expression	 pattern	 of	 Nedd8,	 the	 marker	 for	 Cullin	 activity,	
during	 AchR	 clustering.	 Following	 48	 hours	 of	 agrin	 stimulation,	 we	 found	 a	 strong	
increase	in	Nedd8	levels	at	80	kDa	(Figure	8B	and	Supplementary	Figure	S8B),	suggesting	
an	increase	in	Cullin	E3-ligase	activity	during	this	process.	We	also	observed	a	significant	
increase	 in	 poly-ubiquitylated	 proteins	 (Figure	 8C	 and	 Supplementary	 Figure	 S8C),	
indicating	an	increase	in	protein	degradation	during	AchR	clustering.	 In	order	to	test	 if	
the	 increase	of	poly-ubiquitylation	was	due	 to	 the	 increase	 in	Cullin	 E3-ligase	activity,	
we	 treated	myotubes	with	 both,	 agrin	 and	MLN4924	 (a	 CRL	 inhibitor).	 In	 absence	 of	
Cullin	 activity,	 as	 shown	 by	 the	 loss	 of	 Nedd8	 signal	 around	 80kDa	 (Figure	 8D,	 left	
panel),	 the	 global	 increase	 of	 poly-ubiquitylation	 observed	 in	 control	 conditions	 was	
inhibited	(Figure	8D,	right	panel)	demonstrating	a	causal	role	for	CRLs	in	the	increase	of	
poly-ubiquitylation	during	AchR	clustering.	Altogether,	these	data	indicate	that	Cullin-3	
is	 increased	during	AchR	clustering	 in	 vitro	 and	 that	 increased	Cullin	activity	 is	 in	part	
responsible	for	protein	degradation	during	AchR	clustering.	
	
Following	 these	 results,	 we	 decided	 to	 assess	 NMJs	 in	 vivo,	 specifically	 focusing	 on	
organization	 and	 AchR	 clustering	 in	 skm-KO	 diaphragms.	 We	 performed	
immunofluorescence	analyses	of	post-	and	pre-synaptic	elements.	Our	data	revealed	a	
complete	disorganization	of	the	NMJs	in	muscle	lacking	Cullin-3	(Figure	9A).	While	AchR	
clusters	 were	 aligned	 along	 a	 narrow	 band	 in	 the	 center	 of	 embryonic	 control	
diaphragms,	 they	 appeared	 scattered	 in	 skm-KO	 diaphragms	 (Figure	 9A).	 In	 addition,	
staining	 of	 Synaptophysin/Neurofilament	 indicated	 abnormal	 branching	 and	
arborization	 of	 the	motoneuron	 (Figure	 9A-B),	 likely	 due	 to	 the	mislocalization	 of	 the	
AchR	clusters.	Quantification	showed	almost	a	4	times	 increase	of	the	motor	endplate	
width	 in	 skm-KO	 diaphragms,	 without	 altering	 the	 percentage	 of	 innervated	 AchRs	
clusters	 (Figure	 9C).	 These	 data	 suggest	 that	 the	 motoneuron,	 while	 hyper-arborized	
and	 branched,	 was	 able	 to	 connect	 with	 the	 post-synaptic	 element	 during	 muscle	
development.	We	also	noticed	that	AchR	clusters	were	smaller	in	diaphragms	of	skm-KO	
embryos	 compared	 to	 controls	 (Figure	 9D)	 due	 to	 an	 overrepresentation	 of	 small	
clusters	and	the	absence	of	large	ones.	
Because	we	showed	previously	that	loss	of	Cullin-3	leads	to	an	accumulation	of	ACTN1	
in	 muscles,	 we	 assessed	 if	 ACTN1	 overexpression	 could	 be	 responsible	 for	 the	 NMJ	
phenotype.	 We	 differentiated	 C2C12	 overexpressing	 HA-ACTN1	 or	 HA	 for	 5	 days,	
followed	by	agrin-induced	AchR	clustering.	Analysis	of	cluster-size	distribution	showed	a	
shift	towards	accumulation	of	small	clusters	and	an	absence	of	large	ones	in	HA-ACTN1	
expressing	 cells	 (Figure	 9E),	 which	 is	 reminiscent	 of	 the	 observations	 made	 in	 the	
diaphragms	of	skm-KO	embryos.	In	addition,	a	21%	decrease	in	the	average	AchR	cluster	
length	was	found	in	myotubes	expressing	HA-ACTN1	(Supplementary	Figure	S8D-E).	





Mutations	 in	 several	 substrate	 adaptors	 for	 Cullin-3	 (i.e.	 KBTBD13,	 KLHL9,	 KLHL40,	
KLHL41)	 are	associated	with	 the	development	of	distal	 and	nemaline	myopathies	 (13-
17).	In	order	to	test	the	relevance	of	our	findings	for	human	health,	we	analyzed	muscle	
samples	 from	 nemaline	 myopathy	 patients	 with	 mutations	 in	 the	 Cullin-3	 substrate	
adaptor	 KBTBD13	 (16),	 TPM2	 (Chr9(GRCh37):g.35685480A>G,	





the	 presence	 of	 nemaline	 bodies	 in	 our	KBTBD13	patients	 through	Gomori	 trichrome	
staining	 (Figure	 10A).	 We	 then	 investigated	 protein	 levels	 of	 Actinin	 isoforms.	 While	
levels	of	ACTN2	and	ACTN3	were	mainly	unchanged	across	the	patients	and	controls,	we	
found	a	striking	 increase	 in	ACTN1	and	ACTN4	 levels	only	 in	KBTBD13	patients	 (Figure	
10B),	mimicking	results	obtained	in	the	muscles	of	skm-KO	embryos.	Finally,	we	asked	if	




Altogether,	 these	 data	 reveal	 an	 abnormal	 accumulation	 of	 non-muscle	 ACTN1	 and	
ACTN4	in	nemaline	myopathy	patients	with	mutations	in	KBTBD13,	which	encodes	for	a	
Cullin-3	related	protein.	 In	addition,	we	unravel	 that	ACTN1	and	ACTN4	accumulate	 in	






It	 has	 been	 recently	 shown	 that	mice	 lacking	 Cullin-3	 develop	 severe	muscle	 atrophy	
and	cardiomyopathy	but	the	responsible	molecular	mechanism	has	not	been	identified	
(20).		
While	Nedd8,	 the	crucial	 regulator	 for	CRL	activity	 is	 largely	downregulated	 in	a	 lot	of	
mature	 tissues,	 its	 expression	 remains	 high	 in	 differentiated	 muscles	 (i.e.	 heart	 and	
skeletal	muscles)	 (24),	 suggesting	 important	 roles	 for	 CRLs	 in	 these	 tissues.	 Our	 data	
show	 for	 the	 first	 time	 that	 substrate	 adaptors	 of	 Cullin-3	 display	 diverse	 expression	
patterns	 in	 various	 skeletal	 muscle	 types,	 with	 diaphragm	 muscles	 emerging	 as	 a	
hotspot	for	their	expression.		Absence	of	Cullin-3	impairs	the	UPS,	and	is	characterized	
by	a	decrease	in	protein	neddylation	and	poly-ubiquitylation,	 in	differentiating	skeletal	
muscles.	 These	 findings	 suggest	 that	 Cullin-3	 is	 a	 major	 active	 CRL	 during	 muscle	
development.		
Cullin-3	 skm-KO	 mice	 exhibit	 severe	 hypotrophy	 of	 myofibers	 and	 die	 within	 a	 few	
minutes	 after	 birth.	 Cullin-3	 depleted	 myoblasts	 (skm-KO	 satellite	 cells	 and	 C2C12	
treated	with	 Cullin-3	 siRNA),	 while	 able	 to	 express	myogenic	 factors,	 were	 unable	 to	
form	large	myotubes,	suggestive	of	impaired	myoblast	fusion.	Comparisons	with	mouse	









treatment	 in	 a	 KLHL40-related	 nemaline	 myopathy	 patient	 (41),	 we	 asked	 if	 Cullin-3	
could	 also	 be	 required	 for	 NMJ	 formation	 and	 function.	 Our	 data	 uncovered	 a	 new	
function	for	Cullin-3	during	development	of	NMJs,	an	essential	process	for	myogenesis	
and	 muscle	 growth	 (40).	 	 We	 demonstrated	 that	 Cullin-3	 and	 CRL	 activity	 increases	
during	 AchR	 clustering,	 and	 is	 required	 for	 the	 increased	 level	 of	 poly-ubiquitylated	
proteins	 occurring	 during	 this	 process.	 Increasing	 evidence	 suggests	 that	 protein	
ubiquitylation	 may	 play	 an	 important	 role	 in	 regulating	 synapse	 development	 (46).	
Interestingly,	it	was	demonstrated	that	RPY-1,	the	homolog	of	Rapsyn	in	C.	elegans,	can	
be	 degraded	 by	 Cullin-3	 (47,	 48).	 While	 those	 findings	 link	 Cullin-3	 with	 NMJ	
development	 in	 nematodes,	 this	 mechanism	 has	 not	 been	 further	 investigated	 in	
mammals.	
In	 this	 study,	we	 found	 that	 loss	of	Cullin-3	 in	vivo	 an	 in	vitro	 led	 to	disorganized	and	
smaller	 AchR	 clusters,	 resulting	 in	 hyper-arborization	 of	 the	 motoneuron.	 Of	 note,	
Cullin-5	 and	 -2	 have	 already	 been	 linked	 to	 the	 development	 of	 NMJs	 in	Drosophila	




On	 the	 molecular	 level,	 our	 proteome	 analysis	 of	 diaphragm	 muscles	 revealed	 the	
deregulation	 of	 proteins	 involved	 in	 muscle	 metabolism	 and	 mitochondria,	 calcium	
handling,	 protein	 degradation,	 actin	 cytoskeleton	 modulation,	 as	 well	 as	
ribonucleosome	and	DNA-associated	proteins.	Our	proteome	analysis	diverges	from	the	
recently	published	Cullin-3	knockout	model	(20).	An	explanation	for	this	discrepancy	is	
that	 the	 authors	 performed	 proteome	 analysis	 of	whole	 hindlimb	 muscles,	 while	 we	





identifying	changes	 that	are	actually	due	 to	non-muscle	cells,	 such	as	 fibroblasts	 from	
connective	tissue,	adipocytes	or	endothelial	cells.		
The	 deregulation	 of	 non-muscle	 ACTN1	 and	 ACTN4,	 Vinculin,	 Filamin-C,	 Cofilin-2,	
Myotilin	or	Xirp1	triggered	our	attention.	Cullin-3	and	BTB-domain	containing	proteins	
have	 already	 been	 shown	 to	 act	 as	 organizers	 of	 the	 cytoskeleton	 in	 Drosophila	
melanogaster	(50,	51).	The	remodeling	of	the	actin	cytoskeleton	is	an	essential	step	for	
efficient	 myoblast	 fusion	 (37)	 and	 for	 AchR	 clustering	 at	 the	 NMJ	 (52,	 53).	 While	





two	 non-muscle	 isoforms	 ACTN1	 and	 ACTN4.	 Alpha-Actinins	 are	 essential	 for	 the	
stability	and	the	architecture	of	the	cytoskeleton,	and	mutations	in	these	genes	lead	to	




specific	 biological	 roles.	 In	 this	 study,	 we	 show	 that	 during	 normal	 myoblast	




the	 loss	 of	 Cullin-3	 in	 muscle	 cells	 results	 in	 accumulation	 of	 non-muscle	 ACTN1.	
Overexpression	 of	 ACTN1	 in	 myoblasts	 was	 sufficient	 to	 recapitulate	 most	 of	 the	
phenotype	of	skm-KO	cells,	characterized	by	fusion	and	AchR	clustering	defects	as	well	
as	 myofiber	 hypotrophy,	 suggesting	 that	 ACTN1	 and	 ACTN4	 play	 different,	 even	
opposite	 roles	 in	 developing	 muscles.	 Contrasting	 roles	 for	 ACTN1	 and	 ACTN4	 have	






with	 early	 onset	 nemaline	 myopathies.	 Nemaline	 myopathies	 are	 characterized	 by	
nemaline	 bodies	 (protein	 aggregates)	 in	 myofibers,	 and	 are	 often	 associated	 with	
muscle	weakness	(69).	Proteins	constituting	nemaline	bodies	include	Actin	(70),	Filamin-
C	 (71),	 Telethonin	 (72),	 Myozenin	 (73),	 Myopalladin	 (74)	 or	 Myotilin	 (75).	 While	
sarcomeric	 ACTN2	 is	 also	 thought	 to	 be	 a	 major	 constituent	 (71,	 76,	 77),	 studies	
investigating	 whether	 levels	 of	 muscle	 alpha-Actinins	 are	 changed	 in	 these	 patients	
show	 conflicting	 results,	 depending	 on	 the	 used	method,	 and	whether	 the	 employed	
antibodies	have	been	specific	to	one	alpha-Actinin	isoform	(76-79).	Non-muscle	ACTN1	
and	 ACTN4	 have	 never	 been	 investigated	 per	 se	 in	 nemaline	 myopathy	 patients	 but	
abnormal	deposition	of	ACTN1	proteins	in	clusters	has	been	observed	in	cardiomyocytes	
from	 patients	 with	 dilated	 cardiomyopathy	 or	 chronic	 pressure	 overload	 (80),	
representing	 a	 biomarker	 for	 the	 disease.	While	 these	 data	 do	 not	 demonstrate	 that	
ACTN1	 accumulation	 is	 causative	 for	 the	 cardiac	 disease,	 they	 are	 suggestive	 of	 an	
involvement	 in	 the	 pathogenic	mechanism.	 In	 addition,	 ACTN1	 interacts	 with	 UDP-N-
acetylglucosamine	2-epimerase/N-acetylmannosamine	kinase	 (GNE),	 an	enzyme	 linked	
to	hereditary	inclusion	body	myopathy	(HIBM)(81).		




While	 further	 studies	 are	 required	 to	 know	 the	 extent	 of	 non-muscle	 alpha-Actinin	
expression	 in	 nemaline	 myopathy	 patients,	 ACTN1	 and	 ACTN4	 should	 now	 be	
considered	as	constituents	of	nemaline	bodies	in	some	patients.			
Indeed,	 a	 correlation	 between	 ACTN1	 or	 ACTN4	 protein	 levels	 and	 severity	 of	 the	
disease	would	be	of	 clinical	 interest.	 An	 interesting	 feature	 of	 patients	with	KBTBD13	
mutation	resides	in	the	lack	of	cardiac	phenotype	(16).	 In	contrast	to	skeletal	muscles,	
heart	development	does	not	 rely	on	 cell	 fusion	events.	 This	developmental	difference	
may	contribute	to	protecting	the	heart	from	the	consequences	of	ACTN1	accumulation.	
	
	To	 summarize,	 we	 propose	 that	 Cullin-3	 critically	 contributes	 to	 actin	 cytoskeleton	
remodeling	to	allow	for	optimal	myoblast	fusion,	differentiation	and	clustering	of	AchRs.	
We	 propose	 that	 non-muscle	 ACTN1	 and	 ACTN4	 are	 a	 new	 target	 for	 Cullin-3	 during	
myogenesis.	 Mutations	 in	 Cullin-3	 substrate	 adaptors	 such	 as	 KBTBD13,	 leads	 to	
pathological	non-muscle	Actinin	accumulation	 in	patients	 (Figure	11).	This	 finding	may	
represent	 a	 new	 unifying	 pathogenic	 mechanism	 for	 the	 etiology	 of	 Cullin-3	 related	







(21).	 	 We	 generated	 constitutive	 skeletal	 muscle	 specific	 (skmKO-Cul3)	 and	 inducible	
skeletal	muscle	specific	(iCul3-KO)	Cullin-3	knockouts,	by	breeding	floxed-Cul3	mice	with	
mice	expressing	the	Cre-recombinase	under	control	of	the	Myogenin	promoter	(22),	or	




Mouse	muscle	 samples	were	 snap	 frozen	 in	 liquid	 nitrogen	 and	 stored	 at	 -80°C.	 Cells	
were	washed	with	PBS,	then	lysed	using	TRIzol	reagent	(ThermoFisher	Scientific).	Total	
RNA	 from	muscles	or	 cells	was	extracted	according	 to	 the	manufacturers	 instructions.		
Purity	of	RNA	was	assessed	by	a	ratio	of	absorbance	at	260nm	and	230nm	>1.7.	200ng	
of	RNA	was	used	for	reverse	transcriptase	reaction	using	the	Maxima	First	Strand	cDNA	




Beverly,	 MA)	 and	 a	 CFX96	 thermocycler	 (BioRad;	 Hercules,	 CA).	 Samples	 were	





Mouse	 primary	 myoblasts	 were	 obtained	 by	 dissecting	 the	 diaphragm	 and	 tongue	
muscles	 from	 E18.5	 embryos.	 Myoblasts	 were	 isolated	 and	 cultured	 as	 previously	
described	(11).		
siRNA	
Proliferating	 C2C12	 cells	 were	 transfected	 with	 siRNA	 directed	 against	 Cullin-3	 (ON-
TARGETplus	 mouse	 Cullin-3	 (26554);	 GE	 Healthcare	 Dharmacon),	 ACTN1	 (ON-
TARGETplus	 mouse	 Actn1	 (L-066191-00-0005)	 or	 scrambled	 control	 (ON-TARGETplus	
non-targeting	 siRNA	 #1;	 GE	 Healthcare	 Dharmacon)	 using	 DharmaFECT	 1	 transfection	








on	 nitrocellulose	 membranes	 (BioRad).	 Membranes	 were	 incubated	 with	 blocking	
solution	 (TBS-Tween	 containing	 5%	 BSA)	 for	 1	 hour	 at	 room	 temperature,	 then	
incubated	 with	 primary	 antibodies	 (Supplementary	 Table	 2)	 in	 blocking	 solution	
overnight	at	4°C.	After	washing,	secondary	HRP-linked	antibodies	(DAKO,	Cell	Signaling)	
were	applied	for	1	hour	at	room	temperature.	After	washing,	antibody-bound	proteins	
were	visualized	on	X-ray	 films	or	by	BioRAD	 imager.	Quantification	of	band	 intensities	
was	 performed	 using	 ImageJ	 software	 (1.48v)	 or	 BioRAD	 Image	 Lab	 (v5.2.1).	 Uncut	
immunoblot	images	can	be	found	in	the	supplementary	data	section.	
Quantitative	proteome	analysis	of	skeletal	muscle	
Proteins	were	 isolated	 form	diaphragms	by	 lysis	 into	 ice-cold	 isolation	buffer	 (300mM	
KCl,	 30mM	 PIPES	 pH6.6,	 0.5%	 NP-40,	 1x	 protease	 inhibitor	 (Roche),	 1x	 Phos-Stop	
(Roche)).	Insoluble	proteins	were	removed	by	centrifugation	(14,000	rpm,	10	minutes	at	
4ºC),	 and	 the	 supernatant	was	 diluted	 1:4	with	 ice	 cold	 dilution	 buffer	 (1x	 Phos-Stop	
(Roche),	0.5%	NP-40,	1mM	DTT).	Precipitation	of	acto-myosin	components	was	done	by	
centrifugation	 (14,000rpm,	 15	minutes	 at	 4ºC),	 and	 the	 remaining	 supernatant	 snap-
frozen	for	further	analysis	by	mass-spectrometry.		
Proteins	destined	 for	mass-spectrometry	were	digested	by	 tryptic	digest,	differentially	
labeled	 for	 iTRAQ	 and	 analyzed	 in	 a	 SciEx	 QTOF5600	 system.	 Collected	 spectrograms	
were	 further	 analyzed	 and	 quantified	 using	 Peaks	 (83).	 A	 full	 dataset	 of	 identified	
proteins	was	deposited	at	the	Mendeley	repository	(84).	Bioinformatic	enrichment	and	
pathway	 analysis	was	 done	 using	Metascape	 (http://metascape.org/;	 (85)),	Morpheus	





all	 data	 was	 done	 by	 either	 using	 ANOVA	 comparison	 followed	 by	 correction	 for	
multiplicity	of	 testing	using	Bonferroni's	multiple	 comparisons	 test,	or	unpaired	 t-test,	
performed	 using	 Excel	 (Microsoft)	 or	 GraphPad	 Prism	 version	 7	 for	 Mac	 (GraphPad	
Software,	 http://www.graphpad.com/).	 Results	 are	 presented	 as	 means	 ±	 standard	




For	 expression	 of	 HA-ACTN1	 in	 C2C12	 cells,	 cDNA	 was	 isolated	 by	 RT-PCR	 on	 mRNA	
extracted	 from	 proliferative	 C2C12.	 Oligonucleotides	 used	 for	 amplification	 were	 the	
following:	 ACTN1.fwd:	 GATGGCTAGCATGGACCATTATGATTCCCAG;	 ACTN1.rev:	
CATGAGCTCGAGGTCGCTCTCGCCATACAG.	PCR	products	were	cloned	into	a	custom	built	
HA-vector	 (12).	 HA-ACTN1	 or	 HA-control	 transfected	 cells	 were	 selected	 with	 G-418	




Cells	were	 rinsed	one	 time	with	PBS,	 fixed	 for	15	minutes	with	4%	paraformaldehyde	
and	rinsed	3	times	with	PBS.	Mouse	muscles	were	snap-frozen	in	 isopentane	cooled	in	
liquid	 nitrogen	 and	 stored	 at	 −80	 °C	 until	 sectioning.	Muscles	were	 sectioned	 using	 a	
Leica	 cryostat.	 Sections	 were	 fixed	 in	 ice-cold	 acetone	 for	 5	 minutes,	 followed	 by	
rehydration	in	1x	PBS	for	10	minutes.	Cells	or	muscle	slides	were	then	permeabilized	for	
10	minutes	 in	 1xPBS	 supplemented	 with	 0.2%	 Triton	 X-100	 (Sigma	 Aldrich;	 St.	 Louis,	
MO),	 washed	 3	 times	 with	 PBS	 and	 incubated	 in	 blocking	 solution	 (Gold	 Buffer	 [GB,	
150mM	 NaCl,	 20mM	 Tris	 pH7.4]	 supplemented	 with	 1%	 BSA)	 for	 1	 hour	 at	 room	
temperature	 before	 incubation	 with	 primary	 antibodies	 (Supplementary	 Table	 2)	 in	
blocking	 solution.	 Primary	 antibodies	 were	 either	 incubated	 for	 2	 hours	 at	 room	
temperature,	or	overnight	at	4°C.	Following	incubation,	cells	were	washed	three	times	
for	 5	 minutes	 with	 PBS,	 and	 incubated	 with	 secondary	 antibodies	 (all	 from	 Jackson	
ImmunoResearch	Laboratories	Inc.;	West	Grove,	PA)	diluted	into	blocking	solution	for	1	
hour	 at	 room	 temperature.	 Secondary	 antibody	 mixtures	 also	 contained	 DAPI	 (4’,	 6’	
diamidino-2-phenylindol)	 and/or	 fluorescently	 linked	 alpha-bungarotoxin	 (BGTX;	
Molecular	 Probes,	 ThermoFisher	 Scientific),	 Alexa	 Fluor	 555	 conjugate	 of	wheat	 germ	
agglutinin	(WGA;	ThermoFisher	Scientific)	or	fluorescently	labeled	phalloidin	(Molecular	
Probes;	ThermoFisher	Scientific)	when	appropriate.	After	washing	three	times	with	PBS	
for	 5	 minutes,	 cells	 were	 mounted	 using	 fluorescent	 mounting	 medium	 (Dako;	
Carpinteria,	 CA).	 Microscopy	 was	 performed	 using	 an	 Olympus	 FV1000	 confocal	
microscope	using	either	 the	20x	air	objective,	 the	40x	or	63x	oil	 immersion	objective,	
zoom	 rates	 between	 1	 and	 3,	 and	 imaged	 in	 sequential	 scanning	mode.	 Images	were	
analyzed	using	ImageJ	(NIH).	
Stimulation	of	AchR	clustering	and	quantification	in	C2C12	myotubes	











diagnostic	and	 research	 investigation.	Studies	were	performed	 in	accordance	with	 the	
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Figure	 1.	 Deletion	 of	 Cullin-3	 in	 skeletal	 muscles	 affects	 the	 ubiquitin-proteasome	
system.		
(A)	 Immunoblot	 analysis	 showing	 loss	 of	 Cullin-3	 protein	 only	 in	 skeletal	 muscle	 (sk.	























(A)	 Body	 weight	 analysis	 of	 E18.5	 embryos	 (n=43	 for	 ctl,	 n=79	 for	 heterozygous	
(f/+;cre+)	 and	 n=41	 for	 skm-KO).	 ****P<0.001	 by	 Anova	 and	 Bonferroni's	 multiple	
comparisons	 test.	 (B)	Diaphragm	weight	analysis	 revealing	a	 strong	muscle	atrophy	of	
E18.5	skm-KO	embryos.	(n=10	for	ctl,	n=19	for	heterozygous	(f/+;cre+)	and	n=8	for	skm-
KO).	 ***P<0.0001	 by	 Anova	 and	 Bonferroni's	 multiple	 comparisons	 test.	 (C)	 Cross-
section	of	E18.5	diaphragms	stained	with	Hematoxylin-Eosin	showing	a	thinner	muscle	
in	 skm-KO.	 Scale	 bar	 =	 1mm.	 (D)	 Immunoblot	 analysis	 unraveling	 a	 decrease	 in	
expression	 of	 muscle	 maturation	 markers	 in	 skm-KO	 diaphragms	 (n=3	 for	 each	












genotype	 and	 >11554	 fibers	 per	 genotype).	 (C)	 RT-PCR	 analysis	 of	 Cullin-3	 and	
Cyclophilin	B	 (CycloB)	 in	 satellite	 cells	 isolated	 from	E18.5	ctl	 and	 skm-KO	 diaphragms	
over	3	days	of	differentiation	in	culture.	Pro:	Proliferation;	D1-3:	Differentiation	day	1	to	
3.	(D)	Immunofluorescence	of	satellite	cells	fixed	after	three	days	of	differentiation	and	
stained	 with	 MyHC	 and	 β-Actin	 antibodies.	 Scale	 bar	 =	 100µm.	 (E)	 Immunoblots	 of	
Cullin-3,	MyHC	and	β-Actin	on	C2C12	myotubes	transfected	with	a	siRNA	against	Cullin-3	
or	a	scrambled	siRNA,	showing	efficient	knockdown.	(F)	Fusion	index	(number	of	nuclei	
per	 myotube)	 of	 C2C12	 cells	 transfected	 with	 a	 Cullin-3	 or	 a	 scrambled	 siRNA	 and	








(A)	 Immunoblot	 analysis	 showing	 the	 pattern	 of	 expression	 of	 Cullin-1,	 Cullin-3	 and	
select	Cullin-3	substrate	adaptors	 in	various	mouse	skeletal	muscles.	Myomesin-3	 (87)	
was	 used	 as	 fiber-type	 marker.	 Gas:	 Gastrocnemius;	 Sth:	 sternohyoideus;	 Pem:	
pectoralis	 major;	 Dia:	 diaphragm;	 IO:	 internal	 oblique;	 Pei:	 pectoralis	 minor;	 Mas:	
massester;	Tri:	triceps,	Bib:	biceps	brachii;	Cla:	clavotrapezius;	EDL:	extensor	digitorum	
longus;	 TA:	 tibialis	 anterior;	 Ste:	 sternomastoideus;	 Sol:	 soleus.	 (B)	Volcano	plot	 of	 all	
identified	 deregulated	 proteins	 in	 E18.5	 diaphragms	 of	 skm-KO	 following	 iTRAQ	mass	
spectrometry	 (3	 diaphragms	 have	 been	 pooled	 per	 sample	 and	 3	 samples	 for	 each	
genotype	 have	 been	 analyzed).	 (C)	 Volcano	 plot	 highlighting	 deregulated	 proteins	









(A)	 Immunoblot	 analysis	 showing	 overexpression	 of	 ACTN1	 in	 C2C12	 cells	
overexpressing	 HA-ACTN1	 construct.	 Pro:	 proliferation;	 D5:	 differentiation	 day	 5.	 (B)	
Immunofluorescence	staining	of	HA	(ctl)	and	HA-ACTN1	overexpressing	myotubes	with	
sarcomeric	myosin	antibody	and	DAPI	after	5	days	of	differentiation.	Scale	bar	=	200µm.	





















acetylcholine	 receptor	 (AchR)	 clustering.	 (A,	 B)	 Immunofluorescence	 staining	 of	 the	
pre-	 and	 postsynaptic	 elements	 of	 E18.5	 NMJs	 in	 ctl	 and	 skm-KO	 diaphragms	 with	
antibodies	 against	 Neurofilament	 and	 Synaptophysin	 (NF/Syn)	 and	 fluorescent	
Bungarotoxin	 (BGTX)	 showing	 (A)	 increased	area	of	 the	motor	endplate,	 dispersion	of	
AchR	clusters	across	the	diaphragm	and	hyper-arborization	of	the	motoneuron	in	skm-
KO,	but	(B)	normal	innervation	of	the	NMJ.	(A)	Scale	bar	=	100µm.	(B)	Scale	bar	=	20µm.	
(C)	Quantification	 of	NMJ	 endplate	widths	 (left	 panel;	 Box	 and	whiskers	 plot	 showing	
min	 to	max	 values;	 average	 is	 shown	 as	 +)	 and	 innervated	 AchRs	 (right	 panel)	 in	 the	








Figure	 10.	 Specific	 accumulation	 of	 non-muscle	 alpha-Actinins	 in	 muscle	 tissues	 of	
patients	 with	 Cul3-related	 nemaline	 myopathies.	 (A)	 Gomori	 Trichrome	 stain	 of	
skeletal	muscle	cross-sections	from	a	healthy	individual	and	a	patient	with	a	mutation	in	




and	ACTN4)	was	observed	 in	 samples	 of	 patients	with	mutations	 in	KBTBD13.	Muscle	
alpha-Actinins	(ACTN2	and	3)	did	not	show	abnormal	accumulation.	Porin	and	Ponceau	
stain	are	shown	as	 loading	controls.	 (C)	 Immunofluorescence	staining	of	cross-sections	
from	muscle	biopsies	of	a	healthy	individual	and	a	patient	with	a	mutation	in	KBTBD13,	
revealing	a	positive	staining	of	nemaline	bodies	with	non-muscle	Alpha-actinins	(ACTN1	
and	4).		Scale	bars	=	100µm	(for	A	and	C).	
		
	 	
	
	
	
Figure	11.	Model	for	the	role	of	Cullin-3	during	muscle	fiber	development.	
S.	Adaptor:	substrate	adaptor,	Rbx1:	RING-box	protein	1,	AchR:	Acetylcholine	Receptor,	
Ub:	Ubiquitin,	N8:	Nedd8	
	
	 	
